PubRank

Virginia F Borges

Author PubWeight™ 30.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 2011 2.12
2 Diagnosis of invasive lobular carcinoma in a young woman presenting with pleomorphic lobular carcinoma in situ on core biopsy. Oncology (Williston Park) 2011 2.08
3 Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study. J Clin Oncol 2003 1.96
4 Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 2009 1.55
5 Treatment-related amenorrhea and sexual functioning in young breast cancer survivors. Cancer 2014 1.48
6 Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol 2014 1.42
7 Body image in recently diagnosed young women with early breast cancer. Psychooncology 2012 1.36
8 Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat 2013 1.24
9 Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium. Cancer Res 2006 1.21
10 Hepatic complications of breast cancer. Lancet Oncol 2009 1.07
11 Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy. Elife 2013 1.02
12 Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance. Breast Cancer Res Treat 2008 1.01
13 Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer. J Clin Invest 2014 0.98
14 Pregnancy-associated breast cancer: an entity needing refinement of the definition. Cancer 2011 0.97
15 Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients. Cancer Immunol Immunother 2013 0.94
16 Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features. Breast Cancer Res Treat 2012 0.91
17 Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling. Breast Cancer Res 2014 0.88
18 Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer. Breast Cancer Res 2009 0.86
19 Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression. Int J Cancer 2014 0.85
20 Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor. Breast Cancer Res Treat 2008 0.84
21 Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema. Neuro Oncol 2014 0.83
22 Influence of human immune cells on cancer: studies at the University of Colorado. Immunol Res 2013 0.80
23 BRCA in breast cancer: from risk assessment to therapeutic prediction. Drug News Perspect 2009 0.80
24 Mammary gland involution as an immunotherapeutic target for postpartum breast cancer. J Mammary Gland Biol Neoplasia 2014 0.79
25 Early-stage BRCA2-linked breast cancer diagnosed in the first trimester of pregnancy associated with a hypercoagulable state. Oncology (Williston Park) 2009 0.77
26 Fulvestrant: a unique antiendocrine agent for estrogen-sensitive breast cancer. Expert Opin Pharmacother 2010 0.76
27 Genomic signatures of pregnancy-associated breast cancer epithelia and stroma and their regulation by estrogens and progesterone. Horm Cancer 2013 0.76
28 The era of high-dose chemotherapy for breast cancer: revisiting a troubled quest. J Clin Oncol 2011 0.75
29 A 40-Year-Old Woman With a New Triple-Negative Breast Mass, Shown on Biopsy to Be Metaplastic Carcinoma. Oncology (Williston Park) 2016 0.75
30 Don't Be Fooled by DCIS. Oncology (Williston Park) 2017 0.75
31 Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies. Oncology (Williston Park) 2016 0.75
32 Role of fulvestrant in sequential hormonal therapy for advanced, hormone receptor-positive breast cancer in postmenopausal women. Clin Breast Cancer 2005 0.75
33 Management of the patient with postpartum breast cancer. Oncology (Williston Park) 2014 0.75
34 Management of young breast cancer patients with de novo genetic mutations. Oncology (Williston Park) 2014 0.75
35 Immunomodulatory therapy in multiple sclerosis and breast cancer risk: a case report and literature review. Clin Breast Cancer 2008 0.75